Physician profile
Matthew Cohen
NPI 1508081787
$5,121.87
in general payments reported to CMS, 2019-2025
35 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $427 · 2021: $770 · 2022: $621 · 2023: $604 · 2024: $792 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Travel and Lodging: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.36 |
| Travel and Lodging | $722.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $911.14 | 2025 | Evoke |
| Spr Therapeutics, INC | $704.60 | 2022-2024 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $668.36 | 2019-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $389.37 | 2019-2022 | |
| Boston Scientific Corporation | $288.41 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $216.43 | 2019-2021 | |
| Lilly USA, LLC | $202.85 | 2019-2023 | Emgality, Reyvow |
| Grt US Holding, INC. | $174.18 | 2021-2022 | |
| Averitas Pharma INC. | $169.05 | 2023-2024 | Qutenza |
| Biodelivery Sciences International, INC. | $166.98 | 2019-2021 | |
| Abbvie INC. | $151.18 | 2023-2025 | Qulipta |
| Pfizer INC. | $145.34 | 2019-2023 | |
| Amgen INC. | $120.71 | 2019-2022 | |
| Vertos Medical, INC. | $101.83 | 2023-2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $93.00 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $85.06 | 2021-2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $65.85 | 2022 | |
| Medtronic, INC. | $57.81 | 2022-2023 | Accurian |
| Vertiflex, INC. | $57.68 | 2019 | |
| Avanos Medical | $45.37 | 2020-2025 | Standard Rf Disposables |
| Novartis Pharmaceuticals Corporation | $34.09 | 2019 | |
| Mdd US Operations, LLC | $30.17 | 2020 | |
| Assertio Therapeutics, INC. | $29.69 | 2019 | |
| Stryker Corporation | $29.29 | 2023 | Optablate |
| Painteq LLC | $23.69 | 2023 | Painteq |
| Spinal Simplicity, LLC | $21.42 | 2024 | Ha Minuteman G3-R |
| Janssen Biotech, INC. | $19.65 | 2025 | Tremfya |
| Daiichi Sankyo INC. | $17.88 | 2019 | |
| Nalu Medical, INC. | $17.73 | 2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $16.37 | 2020 | |
| Zyla Life Sciences, INC. | $15.74 | 2019 | |
| Medtronic USA, INC. | $13.17 | 2019 | |
| Bioventus LLC | $13.09 | 2023 | Stimrouter Implantable Kit |
| Almatica Pharma LLC | $12.62 | 2021 | |
| Redhill Biopharma INC. | $12.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.